Stockscreener 앱 받기
835.99
0.30%
-2.50
시간 외 거래:
835.99
전일 마감가:
$838.49
열려 있는:
$838.49
하루 거래량:
192.48K
Relative Volume:
0.57
시가총액:
$51.99B
수익:
$4.16B
순이익/손실:
$1.29B
주가수익비율:
42.69
EPS:
19.5837
순현금흐름:
$734.26M
1주 성능:
+3.66%
1개월 성능:
+7.73%
6개월 성능:
-8.33%
1년 성능:
+43.90%
1일 변동 폭
$829.60
$841.85
1주일 범위
$799.38
$843.90
52주 변동 폭
$510.06
$934.62
알제넥스 NV ADR Stock (ARGX) Company Profile
Compare ARGX vs VRTX, REGN, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARGX
Argen X Se Adr
|
835.99 | 52.14B | 4.16B | 1.29B | 734.26M | 19.58 |
VRTX
Vertex Pharmaceuticals Inc
|
447.54 | 113.70B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.78 | 65.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.98 | 40.73B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.48 | 32.87B | 742.00K | -1.37B | -1.07B | -7.0731 |
알제넥스 NV ADR Stock (ARGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-12-18 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-11-24 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-09-15 | 재개 | Truist | Buy |
| 2025-09-11 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-08-25 | 개시 | RBC Capital Mkts | Outperform |
| 2025-07-08 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-05-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-03-17 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2025-03-12 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2025-01-17 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2024-11-12 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2024-11-05 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2024-11-01 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-11-01 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-10-10 | 재개 | Raymond James | Strong Buy |
| 2024-10-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-08-06 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-07-25 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-07-23 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-02-15 | 개시 | Wolfe Research | Peer Perform |
| 2023-12-20 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-12-20 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-07-31 | 개시 | Scotiabank | Sector Perform |
| 2023-07-24 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-07-17 | 재개 | Evercore ISI | Outperform |
| 2023-06-15 | 개시 | Societe Generale | Sell |
| 2023-05-31 | 개시 | UBS | Buy |
| 2023-04-25 | 개시 | Citigroup | Buy |
| 2023-03-14 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-12-07 | 개시 | William Blair | Outperform |
| 2022-10-12 | 개시 | Oppenheimer | Perform |
| 2022-07-29 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-06-28 | 재개 | Stifel | Buy |
| 2022-05-03 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-12-08 | 개시 | Wells Fargo | Overweight |
| 2021-11-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-10-29 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-28 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-10-07 | 개시 | Jefferies | Buy |
| 2021-09-23 | 업그레이드 | Redburn | Neutral → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-23 | 개시 | Deutsche Bank | Hold |
| 2021-07-19 | 재개 | Wolfe Research | Outperform |
| 2021-06-18 | 개시 | UBS | Buy |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-05-10 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2021-04-23 | 개시 | Redburn | Neutral |
| 2021-03-05 | 재확인 | H.C. Wainwright | Neutral |
| 2021-02-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-04 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-08-25 | 개시 | Raymond James | Outperform |
| 2020-08-19 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-07-29 | 개시 | H.C. Wainwright | Neutral |
| 2020-02-10 | 개시 | BofA/Merrill | Buy |
| 2019-11-05 | 개시 | Credit Suisse | Neutral |
| 2019-10-31 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2019-10-22 | 개시 | JP Morgan | Overweight |
| 2019-09-27 | 개시 | Wells Fargo | Market Perform |
| 2019-09-16 | 재개 | Cowen | Outperform |
| 2019-06-28 | 개시 | Robert W. Baird | Outperform |
| 2019-01-18 | 재개 | SunTrust | Buy |
| 2019-01-04 | 개시 | Morgan Stanley | Overweight |
| 2018-12-17 | 개시 | Goldman | Buy |
| 2018-12-14 | 개시 | Wolfe Research | Outperform |
| 2018-06-29 | 개시 | Nomura | Buy |
| 2018-04-09 | 개시 | SunTrust | Buy |
| 2018-01-29 | 재확인 | JMP Securities | Mkt Outperform |
모두보기
알제넥스 NV ADR 주식(ARGX)의 최신 뉴스
Stifel raises argenx stock price target on myositis study outlook By Investing.com - Investing.com Australia
Barlow’s Research Roundup: RBC analyst provides praise and top picks in regulated utilities sector - The Globe and Mail
argenx to Present at Upcoming Investor Conferences - GlobeNewswire Inc.
ARGX Stock Price, Quote & Chart | ARGENX SEADR (NASDAQ:ARGX) - ChartMill
Argenx SE stock (NL0010832176): autoimmune drug specialist in focus after recent price strength - AD HOC NEWS
Evercore ISI Raises its Price Target on argenx (ARGX) - Yahoo Finance
ARGX News | ARGENX SEADR (NASDAQ:ARGX) - ChartMill
Jefferies updates franchise picks list, adding AMZN, APP, MCD and more - MSN
ARGX.BR Stock Price, Quote & Chart | ARGENX SE (EBR:ARGX) - ChartMill
argenx SE’s SWOT analysis: stock gains momentum on Vyvgart growth By Investing.com - Investing.com Nigeria
argenx SE’s SWOT analysis: stock gains momentum on Vyvgart growth - Investing.com
argenx SE (ARGX) Stock Price, Trades & News - GuruFocus
Argenx SE stock (NL0010832176): FMR LLC boosts stake amid price gains - AD HOC NEWS
Earnings call transcript: Argenx Q1 2026 beats EPS expectations, stock dips - Investing.com
Argenx Eyes Larger Patient Pool Following Expanded FDA Nod For Lead Drug For Neuromuscular Disease - Sahm
argenx stock gains after FDA expands MG treatment approval By Investing.com - Investing.com South Africa
argenx stock gains after FDA expands MG treatment approval - Investing.com
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG - ChartMill
RBC Capital maintains argenx stock price target at $890 on uptake potential - Investing.com Australia
Earnings call transcript: Argenx beats EPS forecast in Q1 2026 By Investing.com - Investing.com Australia
Earnings call transcript: Argenx beats EPS forecast in Q1 2026 - Investing.com
Argenx beats profit forecasts despite revenue miss - Investing.com
Argenx beats profit forecasts despite revenue miss By Investing.com - Investing.com Canada
argenx posts 63% revenue growth on strong Vyvgart sales By Investing.com - Investing.com South Africa
argenx appoints Karen Massey as CEO, founder moves to chair - Investing.com
argenx appoints Karen Massey as CEO, founder moves to chair By Investing.com - Investing.com India
argenx to Present at BofA Securities 2026 Health Care Conference - ChartMill
argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer - ChartMill
Argenx SE Q1 2026 earnings preview - MSN
Here’s Why Argenx SE (ARGX) Slipped in Q1 - Yahoo Finance
ARGX.BR Technical Analysis | Trend, Signals & Chart Patterns | ARGENX SE (EBR:ARGX) - ChartMill
argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026 - ChartMill
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Regeneron (REGN) - The Globe and Mail
argenx SE Stock Baskets | MEX:ARGXN - GuruFocus
argenx SE Stock Operating Data - GuruFocus
argenx SE (MEX:ARGXN) Stock News, Headlines & Updates - GuruFocus
US-Listed European ADRs Slipped As Drugmakers Weighed On The Tape - Finimize
Argenx SE stock (NL0010832176): Is its rare disease focus strong enough to unlock sustained U.S. gro - AD HOC NEWS
The Bull Case For argenx (ENXTBR:ARGX) Could Change Following New VYVGART Ocular MG Efficacy Data - Yahoo Finance
Argenx SE stock (NL0010832176): Is Vyvgart's momentum strong enough to unlock new upside? - AD HOC NEWS
알제넥스 NV ADR (ARGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.01%
1.84%
자본화:
|
볼륨(24시간):